K2 HealthVentures

K2 HealthVentures is an alternative investment firm focused on providing flexible, long-term financing solutions to innovative private and public companies in the life sciences and healthcare industries. The investment team is comprised of collaborative, experienced professionals with diverse backgrounds in finance and operations, as well as deep domain knowledge across various healthcare sectors. A uniquely flexible, permanent capital structure enables the firm to provide creative, adaptive financing solutions and meet the evolving capital needs of its portfolio companies as they grow. K2HV is driven by dual goals of Profit and Purpose – aiming to fuel the growth of innovative companies that will ultimately improve the lives of patients and giving a percentage of investment profits back to underserved areas in healthcare.

K2 HealthVentures, established in 2018 and headquartered in United States, North America., specializes in Late Stage Venture, Private Equity, Early Stage Venture investments across Consulting, Health Care, Medical, Venture Capital, Biotechnology, Financial Services, Finance, Asset Management, FinTech, Business Development. The organization boasts a portfolio of 41 investments, with an average round size of $62.2M and 21 successful exits. Their recent investments include Hopscotch Primary Care, aMoon Fund, 8VC, CVS Health Ventures, U.S. Medical Management. The highest investment round they participated in was $104.0B. Among their most notable exits are Hopscotch Primary Care and aMoon Fund. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.